WGRX Company Profile and Key Details

NASDAQ : WGRX

Wellgistics Health

$0.39

-0.0101-2.51%

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Wellgistics Health, Inc. (WGRX) stock declined over -2.51%, trading at $0.39 on NASDAQ, down from the previous close of $0.40. The stock opened at $0.42, fluctuating between $0.39 and $0.42 in the recent session.

Stock Snapshot

0.403

Prev. Close

27.5M

Market Cap

0.3928

Day Low

-0.31

P/E Ratio

-1.28

EPS (TTM)

N/A

Cash Flow per Share

0.42

Open

69.99M

Number of Shares

0.422

Day High

17.92%

Free Float in %

N/A

Book Value

458.77K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 09, 2026	0.42	0.42	0.39	0.39	452.8K
Jan 08, 2026	0.42	0.44	0.40	0.40	491.45K
Jan 07, 2026	0.43	0.44	0.40	0.41	413.19K
Jan 06, 2026	0.42	0.44	0.42	0.42	158.85K
Jan 05, 2026	0.44	0.45	0.41	0.42	256.01K
Jan 02, 2026	0.40	0.43	0.39	0.43	228.81K
Dec 31, 2025	0.35	0.42	0.35	0.40	759.38K
Dec 30, 2025	0.37	0.38	0.35	0.37	574.23K
Dec 29, 2025	0.40	0.41	0.38	0.38	403.46K
Dec 26, 2025	0.44	0.44	0.40	0.40	356.75K
Dec 24, 2025	0.42	0.45	0.42	0.43	131.76K
Dec 23, 2025	0.45	0.46	0.42	0.43	420.38K
Dec 22, 2025	0.48	0.50	0.47	0.47	334.84K
Dec 19, 2025	0.48	0.50	0.45	0.49	696.3K
Dec 17, 2025	0.51	0.55	0.50	0.50	242.39K
Dec 16, 2025	0.56	0.57	0.52	0.54	417.89K
Dec 15, 2025	0.57	0.60	0.54	0.58	433.53K
Dec 12, 2025	0.63	0.63	0.57	0.57	260.94K
Dec 11, 2025	0.60	0.63	0.59	0.62	179.17K
Dec 10, 2025	0.61	0.64	0.59	0.61	522.1K

Contact Details

Tampa, FL 33607

United States

https://www.wellgisticshealth.com 844 203 6092

About Company

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Stock Peers

HSIC

-1.36-1.72%

Henry Schein, Inc.$77.64 PDCO

-0.28-0.90%

Patterson Companies, Inc.$31.33 RDGT

0.02+0.72%

Ridgetech Inc.$2.80 GEG

Great Elm Group, Inc.$2.45 SNYR

-0.04-2.16%

Synergy CHC Corp.$1.81 MEHA

-0.02079999-9.42%

Functional Brands, Inc. Common Stock$0.20 ZYXI

0.005+5.12%

Zynex, Inc.$0.10

Company Overview

Wellgistics Health, Inc. (NASDAQ:WGRX) closed at $0.39 USD, losing -$0.01 (-2.51%) from the previous close of $0.40. The stock is currently mid-range between its 52-week high and low $0.34 and $7.04. With a market capitalization of about $27.50 million, Wellgistics Health, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-8.54). Key stats such as the average daily volume over the past year has been around 14.27 million shares, volume is running light vs its 52-week average. Headquartered in Tampa, FL, Wellgistics Health, Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Prashant Patel, the company employs approximately 31 people and listed since February 25, 2025. Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Technical Performance

WGRX has shown mixed momentum, gaining 0.88% over the past week and -43.6% over the past quarter, though year-to-date performance is up 0.88%. Short-term trend indicators are bullishly aligned (SMA20 -13.92%, SMA50 -27.73%, SMA200 -73.31%). The stock’s 14-day RSI is 37.21 (weak momentum), while the ATR of 0.05 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -94.42% below its high and over 17.04% above its low. Average 10-day trading volume of 333.52 thousand shares is below the 3-month average of 14.07 million, indicating normal recent market interest.

Valuation Metrics

Wellgistics Health, Inc. trades at a P/E ratio of -0.4, slightly below the S&P 500 average, with a price-to-sales ratio of 4.89 and a price-to-book ratio of 4.31 trading at moderately above to book value. The P/FCF stands at -3.75, also above market averages.

Dividend & Fair Value

Wellgistics Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.24. This means the shares are trading below this model’s fair value.

Shareholding & Insider Activity

Wellgistics Health, Inc. has 84.06 million shares outstanding. The public float is 12.54 million shares, elevated short interest at 1.37% of float. This equals 814.46 thousand shares. The short ratio is 0.14 days. Institutional investors hold 11.32% of the float. Insiders own 56.78%.

Financial & Profitability Overview

Over the trailing twelve months, Wellgistics Health has not generated any revenue.
On valuation metrics, Wellgistics Health trades at a P/E of -0.40, P/S of 4.89 and P/B of 4.31. Liquidity is tight, with a current ratio of 0.39 and quick ratio of 0.16. Operationally, the company’s inventory turnover is 0.72 and cash conversion cycle is -126.34 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 3.83, supported by a cash flow-to-debt ratio of -0.28.

Price Forecast & Outlook

Our AI price prediction model suggests that Wellgistics Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -23.64%, with price expected at $0.30 by January 23, 2026, within a range of $0.25 to $0.36 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by April 09, 2026, with a range of $0.00 to $0.00. 1-Year Outlook: Projected loss of -89.82%, with price at $0.04 by December 31, 2026, within a range of $0.00 to $0.10.

Key Takeaways

Wellgistics Health, Inc. (NASDAQ:WGRX) shares are flat 0.88% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Wellgistics Health, Inc. trading at a premium to the broader market with a P/E of -0.4. Our AI forecast model points to short-term weakness (-23.64% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term loss (-89.82% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Wellgistics Health, Inc. (WGRX) stock price?

Wellgistics Health, Inc. (NASDAQ: WGRX) stock price is $0.39 in the last trading session. During the trading session, WGRX stock reached the peak price of $0.42 while $0.39 was the lowest point it dropped to. The percentage change in WGRX stock occurred in the recent session was -2.51% while the dollar amount for the price change in WGRX stock was - $0.01.

WGRX's industry and sector of operation?

The NASDAQ listed WGRX is part of Medical - Distribution industry that operates in the broader Healthcare sector. Wellgistics Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of WGRX?

No Data

How WGRX did perform over past 52-week?

WGRX's closing price is 16.93% higher than its 52-week low of $0.34 where as its distance from 52-week high of $7.04 is -94.42%.

How many employees does WGRX have?

Number of WGRX employees currently stands at 31.

Link for WGRX official website?

Official Website of WGRX is: https://www.wellgisticshealth.com

How do I contact WGRX?

WGRX could be contacted at phone 844 203 6092 and can also be accessed through its website. WGRX operates from 3000 Bayport Drive, Tampa, FL 33607, United States.

How many shares of WGRX are traded daily?

WGRX stock volume for the day was 458.77K shares. The average number of WGRX shares traded daily for last 3 months was 14.27M.

What is the market cap of WGRX currently?

The market value of WGRX currently stands at $27.50M with its latest stock price at $0.39 and 69.99M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	31
Beta	-8.54
Sales or Revenue	N/A
5Y Sales Change%	-1%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Distribution

WGRX Company Profile and Key Details

Wellgistics Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook